131 Iodine-Tenatumomab
N/A
Report date: 2025/09/04 17:53:57
Base Information
Drug Name131 Iodine-Tenatumomab
Drug Alias Name
Classification +[7]
Mechanisms of Action
Targets
Therapy Area/Indications +[9]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSigma-Tau Spa
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesSigma-Tau Ifr Spa
Active IndicationsN/A
Inactive Indications +[9]
Other Information
ATC CodeN/A
Related LinksDrugBank